The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - AstraZeneca (Inst)
Safety and tolerability of the olaparib tablet formulation in Japanese patients (pts) with advanced solid tumors (ASTs).
 
Yasuo Takahashi
Research Funding - AstraZeneca (Inst)
 
Koshi Fujikawa
Research Funding - AstraZeneca (Inst)
 
Tamotsu Sagawa
Research Funding - AstraZeneca (Inst)
 
Kan Yonemori
Research Funding - AstraZeneca (Inst)
 
Kenji Tamura
Research Funding - AstraZeneca (Inst)
 
Makoto Kodaira
No Relationships to Disclose
 
Taito Esaki
Research Funding - AstraZeneca (Inst)
 
Tsuyoshi Shirakawa
Research Funding - AstraZeneca (Inst)
 
Fumihiko Hirai
Research Funding - AstraZeneca (Inst)
 
Yuki Yokoi
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Toshio Kawata
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Ben Hatano
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca